Goodwin Procter advised SonoThera, Inc. on the deal. SonoThera, Inc. announced its $60.75 million Series A financing round to support the continued development of SonoThera’s ultrasound-guided, nonviral,...
SonoThera’s $60.75 Million Series A Funding
Sanara MedTech’s Acquisition of Precision Healing
Goodwin advised Precision Healing on the deal. Precision Healing announced its acquisition by Sanara MedTech. Precision Healing develops, markets, and distributes advanced wound care and diagnostic products...
Garuda Therapeutics’ Launch and $72 Million Series A Financing
Goodwin Procter advised Garuda Therapeutics on the deal. Garuda Therapeutics announced its launch and $72 million Series A financing led by Aisling Capital, Northpond Ventures, and OrbiMed,...
EQRx’s Merger with CM Life Sciences III
Goodwin Procter advised EQRx on the deal while White & Case LLP advised CM Life Sciences III Inc. EQRx, Inc. announced its definitive merger agreement with CM...
Laronde’s $440 Million Series B Financing
Goodwin Procter advised Laronde on the deal. Laronde announced its $440 million Series B Financing to advance the development of its eRNA platform and a broad pipeline...